tradingkey.logo

Nanovibronix Inc

NAOV
4.020USD
0.0000.00%
종가 02/06, 16:00ET시세는 15분 지연됩니다
4.06M시가총액
손실P/E TTM

Nanovibronix Inc

4.020
0.0000.00%

자세한 내용은 Nanovibronix Inc 회사

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Nanovibronix Inc 정보

종목 코드 NAOV
회사 이름Nanovibronix Inc
상장일Apr 24, 2015
CEOBesser (Doron)
직원 수15
유형Ordinary Share
회계 연도 종료Apr 24
주소969 Pruitt Piace
도시TYLER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호75703
전화19142333004
웹사이트https://nanovibronix.com/
종목 코드 NAOV
상장일Apr 24, 2015
CEOBesser (Doron)

Nanovibronix Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
United States
462.00K
93.52%
New Zealand
20.00K
4.05%
Europe
8.00K
1.62%
Other
4.00K
0.81%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Fri, Jan 2
마지막 업데이트: Fri, Jan 2
주주
주주 유형
주주
주주
비율
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.49%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
기타
98.23%
주주
주주
비율
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.49%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
기타
98.23%
주주 유형
주주
비율
Holding Company
0.76%
Investment Advisor/Hedge Fund
0.49%
Hedge Fund
0.42%
Investment Advisor
0.11%
기타
98.21%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
17
11.24K
1.03%
+4.25K
2025Q3
17
5.95K
0.68%
+2.34K
2025Q2
26
142.96K
5.53%
+80.02K
2025Q1
26
100.49K
7.64%
+70.73K
2024Q4
29
390.46K
7.75%
-206.57K
2024Q3
31
421.26K
15.22%
+83.76K
2024Q2
31
243.60K
8.84%
-214.51K
2024Q1
34
373.91K
18.23%
+170.33K
2023Q4
38
117.62K
5.71%
-262.96K
2023Q3
41
131.29K
7.90%
-1.54K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Alpha Capital Aktiengesellschaft
8.25K
0.76%
+4.93K
+148.55%
May 16, 2025
Geode Capital Management, L.L.C.
5.14K
0.47%
--
--
Nov 30, 2025
Armistice Capital LLC
3.99K
0.37%
+3.99K
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.00K
0.09%
+1.00K
--
Sep 30, 2025
Tower Research Capital LLC
627.00
0.06%
+401.00
+177.43%
Sep 30, 2025
The Vanguard Group, Inc.
189.00
0.02%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
35.00
0%
-1.33K
-97.45%
Sep 30, 2025
Fashek (Christopher M)
34.00
0%
--
--
Oct 27, 2025
SBI Securities Co., Ltd.
15.00
0%
+15.00
--
Sep 30, 2025
BofA Global Research (US)
6.00
0%
+5.00
+500.00%
Sep 30, 2025
더 보기

관련 ETF

이름
비율
데이터 없음

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Aug 08, 2025
Merger
10→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
날짜
배당락일
유형
비율
Aug 08, 2025
Merger
10→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
KeyAI